Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FOLFOXIRI Regimen”

Showing 6 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00778102
What this trial is testing

Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 80
Testing effectiveness (Phase 2)UnknownNCT03487939
What this trial is testing

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsDrug Therapy
China Medical University, China 30
Testing effectiveness (Phase 2)Study completedNCT01328171
What this trial is testing

FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)

Who this might be right for
Metastatic Colorectal Cancer
AIO-Studien-gGmbH 93
Testing effectiveness (Phase 2)UnknownNCT04169347
What this trial is testing

FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Criterium, Inc. 27
Testing effectiveness (Phase 2)UnknownNCT02128425
What this trial is testing

FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 162
Testing effectiveness (Phase 2)Active Not RecruitingNCT03773367
What this trial is testing

Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
Lund University Hospital 60

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation